Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Europap Tezol Kagit Sanayi Ve Ticaret AS
IST:TEZOL.E
|
TR |
|
Everbright Grand China Assets Ltd
HKEX:3699
|
HK |
|
Koshidaka Holdings Co Ltd
TSE:2157
|
JP |
|
Surteco Group SE
XETRA:SUR
|
DE |
|
Samko Timber Ltd
SGX:E6R
|
SG |
|
Boliden AB
OTC:BDNNY
|
SE |
|
U
|
Unitech Electronics Co Ltd
TWSE:3652
|
TW |
|
Catena Media PLC
STO:CTM
|
MT |
Asymchem Laboratories Tianjin Co Ltd
Research & Development
Asymchem Laboratories Tianjin Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
A
|
Asymchem Laboratories Tianjin Co Ltd
SZSE:002821
|
Research & Development
-¥563.4m
|
CAGR 3-Years
1%
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Research & Development
-¥2.9B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Research & Development
-¥7B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Research & Development
-¥356.2m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Research & Development
-¥1.1B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Research & Development
-¥1.4B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
-54%
|
CAGR 10-Years
N/A
|
|
Asymchem Laboratories Tianjin Co Ltd
Glance View
In the bustling industrial landscape of Tianjin, Asymchem Laboratories stands as a beacon of innovation and precision in the biopharmaceutical world. Founded with a vision to harmonize the intricate processes of pharmaceutical development, Asymchem has evolved into a powerhouse of Contract Development and Manufacturing Organization (CDMO) services. The company provides end-to-end solutions in the pharmaceutical sector, specializing in the synthesis and manufacturing of small molecule active pharmaceutical ingredients (APIs). Their sophisticated laboratories and state-of-the-art production facilities serve a global clientele, demanding not only high-quality standards but also a seamless integration of complex processes—from drug discovery through commercialization. Asymchem's business model thrives on the symbiosis between its technical expertise and the ever-growing demand for innovative pharmaceuticals. They offer a comprehensive suite of services including research and development, process optimization, and full-scale commercial production. The company's revenue streams are tied to its ability to win long-term contracts with major pharmaceutical companies, focusing on creating custom-tailored solutions that expedite the drug development timeline while ensuring compliance with stringent regulatory standards. By aligning their operations with the needs of the biopharmaceutical industry, Asymchem secures its positioning as a key player, propelling forward the possibilities of modern medicine while ensuring sustainable growth in the competitive pharmaceutical manufacturing sector.
See Also
What is Asymchem Laboratories Tianjin Co Ltd's Research & Development?
Research & Development
-563.4m
CNY
Based on the financial report for Sep 30, 2025, Asymchem Laboratories Tianjin Co Ltd's Research & Development amounts to -563.4m CNY.
What is Asymchem Laboratories Tianjin Co Ltd's Research & Development growth rate?
Research & Development CAGR 5Y
-20%
Over the last year, the Research & Development growth was 17%. The average annual Research & Development growth rates for Asymchem Laboratories Tianjin Co Ltd have been 1% over the past three years , -20% over the past five years .